DXB vs PYC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

40LOW

PYC

PYC THERAP FPO [PYC]

53MEDIUM

Score Breakdown

DXB PYC
Technical
45
60
Catalyst
48
55
Sentiment
50
50
Fundamental
82
42
Momentum
36
75
Risk Gate
50
50

Key Metrics

DXB Metric PYC
$141.1MMarket Cap$1.5B
3.2MAvg Volume (20d)1.1M
N/AShort Interest+0.3%
$0.66552-Week High$1.755
$0.15852-Week Low$0.848
+2.1%Daily Change-1.3%
$0.240Reference Price$1.530
-594.5%ROE-47.5%
-219.9%Profit Margin-231.3%

Active Signals

DXB Signals

●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-29
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (15% of range)

PYC Signals

●MACD momentum is losing steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Adequate cash runway (7 quarters)
●Very high P/S ratio (74.1x)
●Revenue in sharp decline (-25%)
●Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare DXB and PYC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

DXB vs RAC →DXB vs RNV →DXB vs SHG →DXB vs VHL →EBO vs EMV →
DXB Full Analysis → PYC Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).